•
Jun 26, 2022

Pilgrim's Pride Q2 2022 Earnings Report

Pilgrim's Pride's Q2 2022 results were released, showing significant growth and improved profitability.

Key Takeaways

Pilgrim's Pride reported a strong second quarter in 2022, with net sales reaching $4.63 billion, a 27.3% increase from the prior year. The company's consolidated GAAP operating income margin was 11.1%, and adjusted EBITDA increased by 67.7% year-over-year.

Net sales increased by 27.3% to $4.63 billion compared to the prior year.

Consolidated GAAP operating income margin was 11.1%, with strong performance in the U.S. and Mexico.

Adjusted EBITDA grew by 67.7% year-over-year, reaching $623.3 million with a 13.5% margin.

The company is investing in operational improvements and capacity expansion to support future growth.

Total Revenue
$4.63B
Previous year: $3.64B
+27.3%
EPS
$1.54
Previous year: $0.63
+144.4%
Adjusted EBITDA
$623M
Previous year: $372M
+67.7%
Adjusted EBITDA margin
13.5%
Previous year: 10.2%
+32.4%
Gross Profit
$679M
Previous year: $380M
+78.5%
Cash and Equivalents
$682M
Previous year: $392M
+74.1%
Free Cash Flow
$79.6M
Previous year: $177M
-55.0%
Total Assets
$9.32B
Previous year: $7.75B
+20.3%

Pilgrim's Pride

Pilgrim's Pride

Pilgrim's Pride Revenue by Geographic Location

Forward Guidance

Pilgrim's Pride is making new investments in the US, including expansions, a new conversion plant, and a prepared foods facility, to drive profitable growth and enhance operating margins.

Positive Outlook

  • Expansion of Athens, Georgia facility to enhance service levels and support growth for a Key Customer.
  • Funding for operational excellence improvements via automation throughout our US footprint.
  • Construction of a protein conversion plant for pet food ingredients in Georgia.
  • Development of a Prepared Foods facility in the Southeast USA to cultivate our branded growth and further diversify our portfolio.
  • These investments will enable sufficient capacity for top line growth with Key Customers, enhance operating margins, create value for shareholders, and provide opportunities for team members.

Challenges Ahead

  • Continual cost escalation in the UK and European business requires consistent innovation to drive profitable growth.
  • Seasonal diseases impacted Mexican operations, reducing efficiency in live production.
  • The team will continue to identify ways to leverage our diverse portfolio of offerings and further optimize our production capabilities to alleviate continual cost escalation
  • Volatile environment
  • Mitigate inflationary headwinds

Revenue & Expenses

Visualization of income flow from segment revenue to net income